Travere Therapeutics
TVTX
$5.46
Share price
3.80%
Change (1 day)
-75.85%
Change (1 year)
Categories
Travere Therapeutics (TVTX) - Net assets
Net assets on the balance sheet as of December 2023 : $0.20 B
According to Travere Therapeutics's latest financial reports the company has $0.20 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Travere Therapeutics - Net assets on balance sheet (from 2011 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.20 B | 368.62% |
| 2022-12-31 | $42.85 M | -85.82% |
| 2021-12-31 | $0.30 B | 43.04% |
| 2020-12-31 | $0.21 B | -4.51% |
| 2019-12-31 | $0.22 B | -30.5% |
| 2018-12-31 | $0.31 B | 8.57% |
| 2017-12-31 | $0.29 B | -4.75% |
| 2016-12-31 | $0.30 B | 2.6% |
| 2015-12-31 | $0.29 B | -905.27% |
| 2014-12-31 | $-37.26 M | 89.41% |
| 2013-12-31 | $-19.67 M | 477.11% |
| 2012-12-31 | $-3.41 M | |
| 2012-02-29 | $-0.07 M | |
| 2011-02-28 | $-0.07 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.38 B | 591.81% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $10.67 M | -94.69% | 🇺🇸 USA |